Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
45.00    2.50 (5.88%)
Bid:
44.00
Ask:
46.00
Spread: 2.00 (4.545%)
Market Cap: £86.34m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

Brine Supply Update

23 Nov 2015 07:00

RNS Number : 5415G
Iofina PLC
23 November 2015
 

 

23 November 2015

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

 

Brine Supply Update

 

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, is issuing an update to the market today on the Company's iodine production in the State of Oklahoma.

 

Late last week there was a magnitude 4.7 earthquake with an epicentre approximately 5 miles due south of one of the Company's IOsorb® plants in northwest Oklahoma. There were no injuries to any Iofina employees nor damage to Company facilities. As a result, the Oklahoma Corporation Commission ("OCC") Oil and Gas Conservation Division issued an Implementation Plan to reduce salt water injection in the nearby area. In the coming weeks, the oil and gas producers who own and operate over 20 Salt Water Disposal ("SWD") injection wells in the affected area will likely be reducing injections up to 50% within a 5 mile radius and up to 25% within a 10 mile radius of the affected area at SWDs specified by the OCC. The expected result is anticipated to be a reduction of available brine to IOsorb® plants IO#3 and IO#5 in addition to a possible reduction of brine at plant IO#2. IOsorb® plants IO#4 and IO#6 are not currently affected by this injection reduction plan, but they are located in the area where SWD operational changes could possibly apply at a later date. 

As of today, the ramifications for the Company's iodine production are not certain. The Board is currently estimating that this may reduce Iofina's current production rate of crystalline iodine between 10-20% on a per annum basis from its 5 operating plants.

The Company still anticipates that it will meet H2 production targets of 260-300MT for H2 2015. The Company will be working closely together with its partners to maximize iodine production and revenue. Most of the affected SWD sites where the Company's IOsorb® plants are located are currently injecting volumes in excess of the capacity of Iofina's plants. This was by design to ensure that the Company would have adequate supplies during times of reduced production of brine by the SWD operators. The Company is investigating additional ways to increase water quality and iodine concentrations to improve the overall economics for the Company and its partners.

 

Commenting, President and CEO Tom Becker stated: "While the reduction in brine supply is likely to affect our production at 3 of our 5 IOsorb® plants, we will be working together with our partners to minimize any production losses and together will investigate means to reduce the impact of this decision by the OCC. We are pleased to be on track to meet H2 2015 crystalline iodine production guidance and we intend to provide an update to the market once the impact of this OCC decision is clearer."

 

 

 

 

For further information, please contact:

 

Dr. Tom Becker, CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

 

Christopher Raggett/Giles Rolls/Joanna Scott

finnCap Ltd

Tel: +44 (0)20 7220 0500

 

Rob Collins/Emily Morris

GMP Securities

Tel: +44(0)20 7647 2800

 

Media Contact:

Dominic Barretto/Harriet Jackson

Yellow Jersey PR Limited

Tel: +44 (0)7768 537 739

About Iofina:

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb® technology. Iofina has production operations in the United States, specifically in Montana, Kentucky and Oklahoma. It has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end-products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes. Iofina utilizes its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

www.iofina.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAEFAAASSFAF
Date   Source Headline
16th Dec 20147:00 amRNSBoard Change
8th Dec 20147:00 amRNSExercise of Options and Total Voting Rights
28th Nov 20144:35 pmRNSPrice Monitoring Extension
17th Nov 20147:00 amRNSIssue of Patent and Market Update
30th Oct 20147:00 amRNSExercise of Options and Total Voting Rights
15th Oct 20147:00 amRNSTotal Voting Rights
10th Oct 20142:56 pmRNSTR-1: Notification of Major Interest in Shares
8th Oct 20149:15 amRNSTR-1: Notification of Major Interest in Shares
6th Oct 20147:00 amRNSProduction & Water Permit Update
30th Sep 20147:00 amRNSInterim Results
18th Sep 20147:00 amRNSProduction Update
5th Sep 20147:00 amRNSAppointment of CEO
14th Aug 20147:00 amRNSJuly Production Update
9th Jul 20147:00 amRNSJune Production Update
18th Jun 20147:00 amRNSExercise of Options and Total Voting Rights
10th Jun 20143:42 pmRNSResult of AGM & Appointment of Directors
3rd Jun 20147:00 amRNSIodine Production Update
16th May 20141:58 pmRNSNotice of AGM
6th May 20147:01 amRNSApril Iodine Production Update
29th Apr 20147:00 amRNSSuccessful Completion of Convertible Bond
28th Apr 20147:00 amRNSBoard Changes
25th Apr 20147:00 amRNSFinal Results
23rd Apr 20147:00 amRNSProduction Update
22nd Apr 20147:01 amRNSWater Project Update
15th Apr 20144:40 pmRNSAppointment of Director (amended)
14th Apr 20147:00 amRNSProduction Update
10th Apr 20148:03 amRNSAppointment of Director
7th Apr 20147:00 amRNSHolding(s) in Company
2nd Apr 20144:39 pmRNSHolding(s) in Company
27th Mar 20147:00 amRNSMarket update
20th Mar 20147:00 amRNSResignation and appointment of Director
7th Mar 20147:00 amRNSAmendment to the terms of Convertible Bond
28th Feb 20147:01 amRNSIO#4 and IO#5 Update
3rd Feb 20147:00 amRNSNon-Core Water Project Update
29th Jan 20147:00 amRNSOperational Update
28th Jan 20147:00 amRNSHolding(s) in Company
13th Jan 20147:00 amRNSChange of Adviser
6th Jan 201410:12 amRNSDirector Transfer of Shares
23rd Dec 20137:00 amRNSWater Project Update
17th Dec 20133:35 pmRNSDirector Dealing
17th Dec 201310:27 amRNSDirector Dealing
17th Dec 20137:00 amRNS2013 Review and 2014 Outlook
13th Dec 20132:55 pmRNSWater Permit
29th Nov 20137:00 amRNSDirectors' Disclosure
22nd Nov 20137:00 amRNSBoard Change
20th Nov 20137:00 amRNSOperational Update
12th Nov 20137:01 amRNSGrant of Options to Directors
5th Nov 20131:45 pmRNSChange of Registered Office
31st Oct 20137:00 amRNSCommissioning of IO#3 iodine extraction plant
9th Oct 20137:00 amRNSOperational Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.